With the use of oral semaglutide, there was a significant reduction in insulin dose with 3, 7 and 14 mg in comparison to placebo at weeks 26 and 52
Some patients may experience improvements in sexual function, while others may notice no change or even temporary decreases due to factors such as caloric restriction, fatigue during the adjustment period, or gastrointestinal side effects that affect overall well-being
Clinicians must screen for contraindications before initiating therapy, which include personal or family history of medullary thyroid carcinoma or MEN 2, and hypersensitivity to tirzepatide
Antes de probar Tirzepatida, nunca pens que podra volver a sentirme tan bien
It demonstrated to have a safety profile similar to GLP-1RA not increasing the risk of hypoglycemia ( In the SURPASS-2 study, TZP at the dose of 5, 10, and 15 mg were compared to the GLP-1RA semaglutide (1 mg once weekly) in patients not well controlled in therapy only with metformin (71)